Loading…
avatar for Kelly Robinson

Kelly Robinson

Health Canada
Director, Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics
Kelly joined Health Canada in 2001 and has experience in both the pre-market and post-market review and regulation of biologics and pharmaceuticals. Kelly is the Director of the Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics in the Biologics and Genetic Therapies Directorate where she leads a team of multi-disciplinary scientists and clinicians who are responsible for reviewing biotherapeutic and radiopharmaceutical drug submissions. Kelly is also involved in initiatives such as international work sharing, HTA alignment and policy related to submissions relying on third party data.

My Speakers Sessions

Tuesday, June 16
 

11:30am EDT

 
Wednesday, June 17
 

9:30am EDT